# GSK completes sale of shares in Haleon

- Link: https://www.directorstalkinterviews.com/gsk-completes-sale-of-shares-in-haleon/4121128934
- Published: 2023-10-06T07:10:12+01:00
- Author: Amilia Stone

**[GSK plc](https://www.directorstalkinterviews.com/ftse-company/glaxosmithkline-plc/gsk.l)**(
LON/NYSE:GSK) has announced that, further to its announcement on 5 October 2023,
GSK has agreed to sell 270m ordinary shares in Haleon plc at a price of 328 pence
per share, raising gross proceeds of approximately £885.6m.

Following settlement of the Placing, GSK will hold 685m^(1) ordinary shares in Haleon,
representing approximately 7.4% of the issued share capital of Haleon.

GSK and Pfizer Inc. (which holds a 32% stake in Haleon), have each undertaken not
to dispose of any further shares in Haleon for a period of 60 days following settlement
of the Placing, subject to certain customary exceptions and waiver by BofA Securities
and Citigroup Global Markets Limited.

_^((1)) Excluding shares in Haleon held by the GSK employee share ownership trust._

Share on: